No CrossRef data available.
Article contents
Gastrointestinal Dysmotility as the First Manifestation of Myasthenia Gravis
Published online by Cambridge University Press: 30 May 2022
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Letter to the Editor: New Observation
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation
References
Anderson, NE, Hutchinson, DO, Nicholson, GJ, Aitcheson, F, Nixon, JM. Intestinal pseudo-obstruction, myasthenia gravis, and thymoma. Neurol. 1996;47:985–87. doi: 10.1212/wnl.47.4.985.CrossRefGoogle ScholarPubMed
Pande, R, Leis, AA. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve. 1999;22:1600–602. doi: 10.1002/(sici)1097–4598(199911)22:11<1600::aid-mus19>3.0.co;2–3.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
Mandl, P, Kiss, JP. Role of presynaptic nicotinic acetylcholine receptors in the regulation of gastrointestinal motility. Brain Res Bull. 2007;72:194–200. doi: 10.1016/j.brainresbull.2007.02.005.CrossRefGoogle ScholarPubMed
Vernino, S, Low, PA, Fealey, RD, Stewart, JD, Farrugia, G, Lennon, VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–55. doi: 10.1056/NEJM200009213431204.CrossRefGoogle ScholarPubMed
Dhamija, R, Tan, KM, Pittock, SJ, Foxx-Orenstein, A, Benarroch, E, Lennon, VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2008;6:988–92. doi: 10.1016/j.cgh.2008.04.009.CrossRefGoogle ScholarPubMed
Vernino, S, Cheshire, WP, Lennon, VA. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci. 2001;88:187–92. doi: 10.1016/S1566-0702(01)00239-9.CrossRefGoogle ScholarPubMed
Gerzanich, V, Peng, X, Wang, F, et al. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol. 1995;48:774–82.Google ScholarPubMed
Gilhus, NE, Tzartos, S, Evoli, A, Palace, J, Burns, TM, Verschuuren, JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30. doi: 10.1038/s41572-019-0079-y.CrossRefGoogle ScholarPubMed
Tamburella, C, Parisi, S, Lillo, S, et al. Gastroparesis, thymoma, and asymptomatic myasthenia: a rare clinical scenario. Gastroenterology Insights. 2022;13:27–32. doi: 10.3390/gastroent13010004.CrossRefGoogle Scholar
Parisi, S, Napoli, I, Lillo, S, et al. Spine eburnation in a metastatic lung cancer patient treated with immunotherapy and radiotherapy. The first case report of bystander effect on bone. J Oncol Pharm Pract. 2022;28:237–41. doi: 10.1177/10781552211027348.CrossRefGoogle Scholar
Sindoni, A, Severo, C, Vadala’, RE, et al. Levetiracetam-induced radiation recall dermatitis in a patient undergoing stereotactic radiotherapy. J Dermatol. 2016;43:1440–441. doi: 10.1111/1346-8138.13427.CrossRefGoogle Scholar